A mathematical model of antibody-dependent cellular cytotoxicity (ADCC).

Autor: Hoffman F; Department of Computer Science, University of Oxford, Oxford, UK., Gavaghan D; Department of Computer Science, University of Oxford, Oxford, UK., Osborne J; Department of Computer Science, University of Oxford, Oxford, UK; School of Mathematics and Statistics, University of Melbourne, AUS., Barrett IP; Quantitative Biology, Astrazeneca Ltd., Cambridge, UK., You T; Computational Biology, Astrazeneca Ltd., Alderley Edge, UK; Beyond Consulting Ltd., BioHub, Alderley Park, Cheshire SK12 4TG, UK., Ghadially H; Medimmune Ltd., Cambridge, UK., Sainson R; Medimmune Ltd., Cambridge, UK., Wilkinson RW; Medimmune Ltd., Cambridge, UK., Byrne HM; Department of Computer Science, University of Oxford, Oxford, UK; Mathematical Institute, University of Oxford, Oxford, UK. Electronic address: helen.byrne@maths.ox.ac.uk.
Jazyk: angličtina
Zdroj: Journal of theoretical biology [J Theor Biol] 2018 Jan 07; Vol. 436, pp. 39-50. Date of Electronic Publication: 2017 Sep 29.
DOI: 10.1016/j.jtbi.2017.09.031
Abstrakt: Immunotherapies exploit the immune system to target and kill cancer cells, while sparing healthy tissue. Antibody therapies, an important class of immunotherapies, involve the binding to specific antigens on the surface of the tumour cells of antibodies that activate natural killer (NK) cells to kill the tumour cells. Preclinical assessment of molecules that may cause antibody-dependent cellular cytotoxicity (ADCC) involves co-culturing cancer cells, NK cells and antibody in vitro for several hours and measuring subsequent levels of tumour cell lysis. Here we develop a mathematical model of such an in vitro ADCC assay, formulated as a system of time-dependent ordinary differential equations and in which NK cells kill cancer cells at a rate which depends on the amount of antibody bound to each cancer cell. Numerical simulations generated using experimentally-based parameter estimates reveal that the system evolves on two timescales: a fast timescale on which antibodies bind to receptors on the surface of the tumour cells, and NK cells form complexes with the cancer cells, and a longer time-scale on which the NK cells kill the cancer cells. We construct approximate model solutions on each timescale, and show that they are in good agreement with numerical simulations of the full system. Our results show how the processes involved in ADCC change as the initial concentration of antibody and NK-cancer cell ratio are varied. We use these results to explain what information about the tumour cell kill rate can be extracted from the cytotoxicity assays.
(Copyright © 2017 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE